Recently a number of lidocaine, mexiletine and procainamide analogues were synthesized, replacing their aminoalkyl chains with the rigid and cumbersome quinolizidine nucleus [I]. Most compounds exhibited from moderate to high antiarrhythmic activity, resulting in several cases more active and potent than quìnidìne and lidocaine. Moreover, while quinidine and amiodarone produced a dose dependent prolongation of all the ECC intervals, our best compounds, even at concentrations 10-20 times higher than EC50 for the antiarrhythmic activity, only moderately prolonged the PR and QT intervals, leaving unchanged the QRS complex. These interesting characteristics seem Lo be connected with the presence of quinolizidine ring, and therefore we deemed worthy to investigate other derivatives of these peculiar bicyclic systems. At the moment, sixteen compounds corresponding to the general structures I-IV have been prepared and tested using isolated guinea pig left and right atria electrically driven%2

Quinolizidine derivatives as potent antiarrhythmic agents / I. Vazzana; R. Budriesi; B. Tasso; F. Novelli; P. Ioan; M.P. Ugenti; M. Tonelli; A. Chiarini; F. Sparatore. - STAMPA. - (2008), pp. P-162-P-162. (Intervento presentato al convegno XIX National Meeting on Medicinal Chemistry tenutosi a Verona nel 14-18 September 2008).

Quinolizidine derivatives as potent antiarrhythmic agents

BUDRIESI, ROBERTA;IOAN, PIERFRANCO;UGENTI, MARIA PAOLA;CHIARINI, ALBERTO;
2008

Abstract

Recently a number of lidocaine, mexiletine and procainamide analogues were synthesized, replacing their aminoalkyl chains with the rigid and cumbersome quinolizidine nucleus [I]. Most compounds exhibited from moderate to high antiarrhythmic activity, resulting in several cases more active and potent than quìnidìne and lidocaine. Moreover, while quinidine and amiodarone produced a dose dependent prolongation of all the ECC intervals, our best compounds, even at concentrations 10-20 times higher than EC50 for the antiarrhythmic activity, only moderately prolonged the PR and QT intervals, leaving unchanged the QRS complex. These interesting characteristics seem Lo be connected with the presence of quinolizidine ring, and therefore we deemed worthy to investigate other derivatives of these peculiar bicyclic systems. At the moment, sixteen compounds corresponding to the general structures I-IV have been prepared and tested using isolated guinea pig left and right atria electrically driven%2
2008
XIX National Meeting on Medicinal Chemistry
P-162
P-162
Quinolizidine derivatives as potent antiarrhythmic agents / I. Vazzana; R. Budriesi; B. Tasso; F. Novelli; P. Ioan; M.P. Ugenti; M. Tonelli; A. Chiarini; F. Sparatore. - STAMPA. - (2008), pp. P-162-P-162. (Intervento presentato al convegno XIX National Meeting on Medicinal Chemistry tenutosi a Verona nel 14-18 September 2008).
I. Vazzana; R. Budriesi; B. Tasso; F. Novelli; P. Ioan; M.P. Ugenti; M. Tonelli; A. Chiarini; F. Sparatore
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/66261
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact